Exosens Delivers Strong 9M 2025 Results Driven by Defense Sector
Exosens achieved remarkable growth in the first nine months of 2025, driven primarily by robust demand in the defense sector. The company reported a revenue increase of 23.2%, totaling €327.8 million, compared to the previous year. Continued strength in defense end markets has been a key contributor to this performance, reflecting a solid growth trajectory for Exosens.
Sustained Growth in Key Segments
The Amplification segment proved particularly strong, witnessing a 20.6% growth to €231.8 million, thanks to increasing global demand for night vision applications and image intensifier tubes.
Expansions and Capacity Increases
Exosens is not resting on its laurels; the company plans to enhance production capacity by 40% by 2027, supported by a €20 million investment plan and an additional €17 million for further capacity expansions across Europe and the United States.
Strategic Acquisitions and Market Position
As part of its growth strategy, Exosens has executed several acquisitions, including Noxant and Phasics, to strengthen its technological portfolio and expand into new market sectors. The acquisition of NVLS in July 2025 has already opened doors for Exosens to supply advanced night vision devices to military customers.
Revenue Breakdown
In 9M 2025, the Detection & Imaging segment also saw significant growth, with revenues reaching €97 million, reflecting a 26.2% increase year-on-year. This growth was bolstered by the group’s strategic acquisitions and a solid performance in the defense segment.
Positive Financial Outlook
Looking ahead, Exosens remains optimistic. The company is on track to achieve its financial guidance for the year, expecting continued revenue growth in the high teens and adjusted EBITDA growth in the low twenties percent range. The market trends suggest a favorable environment for defense-related technologies, which Exosens is well-positioned to capitalize on.
Conclusion
Overall, the first nine months of 2025 have set a strong precedent for Exosens’s future, confirming its strategic decisions and market focus. The investments and acquisitions made underscore its commitment to driving innovation while seizing significant market opportunities.
Frequently Asked Questions
What were Exosens' revenue figures for 9M 2025?
Exosens reported revenues of €327.8 million for the nine-month period ending September 2025, marking a 23.2% increase from the previous year.
How is Exosens planning to grow in the future?
The company plans to increase production capacity by 40% through substantial investment and strategic acquisitions to support high demand.
Which segments drove revenue growth for Exosens?
The Amplification segment experienced significant growth, while Detection & Imaging also contributed to overall revenue increases.
What strategic moves has Exosens recently made?
Recent acquisitions, including Noxant and NVLS, have been key to expanding its technological capabilities and market reach.
What is the outlook for Exosens in 2025?
Exosens anticipates continued strong performance with revenue growth in the high teens and adjusted EBITDA growth in the low twenties.
